Two Sigma Investments, LP Homology Medicines, Inc. Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.55 - $3.01 $16,304 - $31,662	10,519 New	10,519 $17,000
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $203,671 - $326,656	-78,335 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.64 - $7.78 $301,370 - $644,137	-82,794 Reduced 51.38%	78,335 $285,000
Q3 2021 Nov 15, 2021	BUY	$6.01 - $8.71 $968,385 - $1.4 Million	161,129 New	161,129 $1.27 Million
Q2 2020 Aug 14, 2020	SELL	$12.07 - $19.34 $200,482 - $321,237	-16,610 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$12.5 - $22.04 $207,625 - $366,084	16,610 New	16,610 $258,000
Q3 2019 Nov 14, 2019	SELL	$14.74 - $22.28 $672,070 - $1.02 Million	-45,595 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $836,668 - $1.38 Million	45,595 New	45,595 $892,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.